Becker's Spine Review3h
Spinal cord stimulators: 3 years of advances
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Becker's Spine Review4h
8 spine, orthopedic acquisitions in Q1
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...
Zacks Investment Research on MSN5d
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
Globus Medical GMED has experienced strong upward momentum in the past year, with its shares rising 41.8%. This has far outpaced the industry’s 7.5% decline and the S&P 500 composite’s 8.8% growth.
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today ...